chronic pain

FDA’s new plan to study opioids’ effectiveness faces resistance
FDA’s new plan to study opioids’ effectiveness faces resistance
Stat
FDA
opioids
chronic pain
Flag link:
2023 starts off with a surge in clinical trials tackling pain
2023 starts off with a surge in clinical trials tackling pain
Clinical Trials Arena
clinical trials
Tris Pharma
Wex Pharmaceuticals
chronic pain
Flag link:
Regeneron scratches NGF inhibitor and cat allergy therapy from pipeline
Regeneron scratches NGF inhibitor and cat allergy therapy from pipeline
Fierce Biotech
Regeneron
chronic pain
cat allergy
Flag link:
Nevro’s AI-Based Spinal Cord Stimulation Device for Chronic Pain Receives FDA Approval
Nevro’s AI-Based Spinal Cord Stimulation Device for Chronic Pain Receives FDA Approval
Xtalks
Medtech
devices
Nevro
FDA
Senza HFX
chronic pain
Spinal Cord Stimulation
Flag link:
Abbott launches upgraded app for chronic pain devices
Abbott launches upgraded app for chronic pain devices
Pharmaforum
Abbott Labs
Medtech
chronic pain
physicians
patients
neurostimulation
mobile apps
Flag link:
Startup gets FDA-clearance for device to treat chronic pain
Startup gets FDA-clearance for device to treat chronic pain
MedCity News
devices
Neuralace Medical
FDA
chronic pain
Flag link:
Nevro touts data supporting use of Senza system to treat diabetic neuropathy pain
Nevro touts data supporting use of Senza system to treat diabetic neuropathy pain
Mass Device
devices
Nevro
Senza
diabetic neuropathy
chronic pain
Flag link:
Eliem exits stealth with $80M to run midphase pain trials, advance pipeline of neuro programs
Eliem exits stealth with $80M to run midphase pain trials, advance pipeline of neuro programs
Fierce Biotech
Eliem Therapeutics
chronic pain
clinical trials
PEA
Flag link:
UCSD spinout pursues gene therapy for chronic pain following positive data in mice
UCSD spinout pursues gene therapy for chronic pain following positive data in mice
Fierce Biotech
UCSD
chronic pain
non-opioid pain treatments
gene editing
Flag link:
Redpin Launches with $15.5 Million Series A to Focus on Pain and Epilepsy
Redpin Launches with $15.5 Million Series A to Focus on Pain and Epilepsy
BioSpace
Redpin Therapeutics
chronic pain
epilepsy
Flag link:
Medtronic Buys Spinal Cord Therapy Company, Adding To Its Chronic Pain Management Platform
Medtronic Buys Spinal Cord Therapy Company, Adding To Its Chronic Pain Management Platform
Motley Fool
devices
Medtronic
Stimegenics
Spinal Cord Stimulation
chronic pain
M&A
Flag link:
How Purdue planted its ‘anti-story’ and delayed the reckoning for its role in the opioid epidemic
How Purdue planted its ‘anti-story’ and delayed the reckoning for its role in the opioid epidemic
Stat
Purdue Pharma
oxycontin
opioids
opioid crisis
chronic pain
Flag link:
Don't Force Patients Off Opioids Abruptly, New Guidelines Say, Warning Of Severe Risks
Don't Force Patients Off Opioids Abruptly, New Guidelines Say, Warning Of Severe Risks
NPR
chronic pain
opioids
opioid crisis
Flag link:
FDA Approves Abbott's 'Low Dose' Neurostimulation Device for Chronic Pain
FDA Approves Abbott's 'Low Dose' Neurostimulation Device for Chronic Pain
Medical Devices and Diagnostics Industry
Abbott Labs
devices
Proclaim XR
Spinal Cord Stimulation
neurostimulation
FDA
chronic pain
Flag link:
Abbott and NIH Join Forces to Advance Neuroscience Research
Abbott and NIH Join Forces to Advance Neuroscience Research
Medical Devices and Diagnostics Industry
Abbott Labs
NIH
devices
chronic pain
R&D
Parkinson's Disease
Flag link:
Could synthetic Botox soothe chronic pain? A new study holds out the possibility
Could synthetic Botox soothe chronic pain? A new study holds out the possibility
Stat
Botox
chronic pain
Allergan
Flag link:
Prescription opioids fail rigorous new test for chronic pain
Prescription opioids fail rigorous new test for chronic pain
Stat
opioids
chronic pain
Flag link:
Purdue Pharma and Geisinger launch wearable tech study of chronic pain patients
Purdue Pharma and Geisinger launch wearable tech study of chronic pain patients
Mass Device
Purdue Pharma
Geisinger
wearables
devices
chronic pain
Medtech
Flag link:
An ethical dilemma for doctors: When is it OK to prescribe opioids?
An ethical dilemma for doctors: When is it OK to prescribe opioids?
Stat
chronic pain
physicians
opioids
opioid crisis
Flag link:
Lilly says new type of pain drug could lessen need for opioids
Lilly says new type of pain drug could lessen need for opioids
Yahoo/Reuters
Eli Lilly
painkillers
tanezumab
chronic pain
opioids
Flag link:

Pages